Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- Analyst Comments: Somaxon, Red Robin, BRE Properties, Banco Santander, Cutera, SINA
Aug 10, 2008 03:48 PM
- Analyst Comments: Somaxon, Bellus Health, Qiagen, CNET Networks, Salix Pharma, VeriFone
May 07, 2008 05:47 PM
- Analyst Comments: Manpower, Kroger, Cosan Limited, Potash Corporation, Somaxon Pharmaceuticals, Crocs, Netflix
Mar 12, 2008 05:21 PM
- Earnings Summary: Tuesday, March 11, 2008
Mar 12, 2008 02:49 AM
- Analyst Comments: Somaxon, EV3, OPNET, Net Servicos, Lincoln National, Equity Residential, CRA International, Cadbury Schweppes
Jan 11, 2008 02:10 PM
- Intriguing Biotech Buying Opportunities
Aug 18, 2007 02:10 PM
- NASDAQ Technical Picture - Solid Extension
Aug 08, 2007 01:27 AM
- Somaxon Pharmaceuticals to Present at the RBC Capital Markets Healthcare Conference
Dec 03, 2008 08:29 AM
- Zacks Analyst Blog Highlights: Mack-Cali Realty Corp., Somaxon Pharmaceuticals, Inc., Syngenta AG, TOTAL and Phoenix Companies
Nov 28, 2008 07:13 AM
- FDA Extends Review of Somaxon Pharmaceuticals’ New Drug Application for Silenor® (Doxepin) by up to Three Months
Nov 24, 2008 08:09 AM
- Somaxon Pharmaceuticals to Present at the Lazard Capital Markets 5th Annual Healthcare Conference
Nov 13, 2008 04:07 PM
- Somaxon Pharmaceuticals Reports 2008 Third Quarter Financial Results
Nov 06, 2008 04:23 PM
- Somaxon Pharmaceuticals to Report 2008 Third Quarter Financial Results and Host Conference Call on November 6, 2008
Oct 28, 2008 08:24 AM
- Somaxon Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference and the Second Annual Natixis Hidden Gems Conference
Sep 30, 2008 04:08 PM
- Zacks Bull and Bear of the Day Highlights: Acergy S.A., CRA International, Somaxon Pharmaceuticals, 3Com Corp. And Taubman Centers
Sep 29, 2008 03:34 PM
- Somaxon Presents Pharmacological Data on Doxepin at the 21st European College of Neuropsychopharmacology Congress
Sep 02, 2008 04:07 PM
- Somaxon Pharmaceuticals to Present at the Thomas Weisel 2008 Healthcare Conference and NewsMakers in the Biotech Industry Conference
Aug 28, 2008 08:09 PM
- Form 4 Raser Jeffrey For: Nov 28 (10K)
Dec 02, 2008 07:22 PM
- Form 4 Pascoe Richard W For: Nov 28 (10K)
Dec 02, 2008 07:22 PM
- Form 4 LITALIEN JAMES J For: Nov 28 (10K)
Dec 02, 2008 07:14 PM
- Form 4 Onaitis Matthew For: Nov 28 (10K)
Dec 02, 2008 07:13 PM
- Form 4 McGilley Meg For: Nov 28 (10K)
Dec 02, 2008 07:13 PM
- Form 4 JONES ROBERT LEWIS For: Nov 28 (10K)
Dec 02, 2008 07:09 PM
- Form 4 Jochelson Philip For: Nov 28 (10K)
Dec 02, 2008 07:09 PM
- Form 4 HALE DAVID F For: Nov 28 (10K)
Dec 02, 2008 07:09 PM
- Form 4 Dube Susan For: Nov 28 (10K)
Dec 02, 2008 07:09 PM
- Form 4 Dorsey Brian For: Nov 28 (10K)
Dec 02, 2008 07:04 PM
Analyst Ratings
|
|
Share Performance
|
Period
|
SOMX
|
Compare to S&P
|
| YTD |
-76.58 %
|
-0.01 %
|
| 4 Weeks |
-10.29 %
|
6.20 %
|
| 12 Weeks |
-70.88 %
|
-54.77 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 1.75 %
|
|
EPS Growth in Last Year: -80.65 %
|
|
Sales Growth in Last Quarter: -0.01 %
|
|
Sales Growth in Last Quarter: -0.01 %
|
|
|
